Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 22, 2019 08:00 ET | Source: VisionGate, Inc.

VisionGate Announces an Exclusive Global License, Manufacturing and Supply Agreement for Iloprost, VisionGate’s Phase 2 Oral Lung Cancer Interception Drug

Seattle, WA, Aug. 22, 2019 (GLOBE NEWSWIRE) -- VisionGate, Inc., a clinical stage oncology pharmaceutical and diagnostics company, announces that it has finalized an exclusive worldwide license...
January 29, 2019 11:32 ET | Source: VisionGate, Inc.

VisionGate Announces Lung Cancer Prevention Trial Progress

Seattle, WA, Jan. 29, 2019 (GLOBE NEWSWIRE) -- VisionGate, Inc., a clinical stage oncology pharmaceutical and diagnostics company, announces that it has selected PCI Pharma Services to provide...
October 11, 2018 10:06 ET | Source: VisionGate, Inc.

VisionGate, Inc. Appoints R. John Glasspool as Chief Operating and Strategy Officer and member of the Board of Directors

Seattle, WA, Oct. 11, 2018 (GLOBE NEWSWIRE) -- VisionGate, Inc., an integrated, clinical-stage, oncology pharmaceutical and diagnostics company, is pleased to announce the appointment of R. John...
September 24, 2018 06:00 ET | Source: VisionGate, Inc.

VisionGate’s Cell-CT™ Platform Uses 3D Cell Morphometry and Artificial Intelligence to Detect an Immunotherapy Predictive Biomarker and Cancer-Associated Cells that have undergone Malignancy Associated Change (MAC) from Liquid Biopsy

Seattle, WA, Sept. 24, 2018 (GLOBE NEWSWIRE) -- VisionGate, a clinical stage oncology pharmaceutical and diagnostics company announces two peer-reviewed poster presentations at the International...
June 14, 2018 14:06 ET | Source: VisionGate, Inc.

VisionGate Announces New Appointment to the Board of Directors

SEATTLE, WA, June 14, 2018 (GLOBE NEWSWIRE) -- VisionGate is pleased to announce the appointment of Dr. James S. (Jim) Burns to the Board of Directors, expanding the depth of biotech leadership and...
April 17, 2018 18:34 ET | Source: VisionGate, Inc.

VisionGate, Inc. Appoints Randal Buness as Chief Financial Officer

SEATTLE, WA, April 17, 2018 (GLOBE NEWSWIRE) -- VisionGate, a clinical stage oncology pharmaceutical and diagnostics company, is pleased to announce the appointment of Randal Buness, CPA, MBA as...
April 16, 2018 09:23 ET | Source: VisionGate, Inc.

VisionGate’s Cell-CT™ 3D Cellular Imaging Platform Detects the Presence of Cancer-Associated Cells (CACs) that have undergone Malignancy Associated Change (MAC)

SEATTLE, WA, April 16, 2018 (GLOBE NEWSWIRE) -- VisionGate, a clinical stage oncology pharmaceutical and diagnostics company, today presented a breakthrough research study demonstrated its Cell-CT™...
April 12, 2018 13:46 ET | Source: VisionGate, Inc.

VisionGate Lung Cancer 3D Cellular Imaging Research to be Featured as a Late-Breaking Abstract at the AACR Annual Meeting 2018

SEATTLE, WA, April 12, 2018 (GLOBE NEWSWIRE) -- VisionGate, Inc., a clinical stage oncology pharmaceutical and diagnostics company, is pleased to announce that new lung cancer 3D cellular imaging...
April 05, 2018 14:03 ET | Source: VisionGate, Inc.

VisionGate is Leveraging the Cell-CT™ Platform to Expand Cancer Diagnostics Services, Biopharmaceutical Services and Cancer Prevention Medicines

SEATTLE, WA, April 05, 2018 (GLOBE NEWSWIRE) -- VisionGate, a clinical stage oncology pharmaceutical and diagnostics company, is pleased to announce today the advancement of its breakthrough...
April 04, 2018 16:21 ET | Source: VisionGate, Inc.

VisionGate Announces Two New Appointments to the Board of Directors

SEATTLE, WA, April 04, 2018 (GLOBE NEWSWIRE) -- VisionGate is pleased to announce the appointment of two new members to the Board of Directors, significantly expanding the depth of biotech...

Next Page keyboard_arrow_right